Targeting the AGE-RAGE/GSK-3β axis in diabetic retinopathy: wound-healing effects of trans-anethole and FPS-ZM1 and putative GSK-3β inhibitory activity of FPS-ZM1
Journal of Basic and Clinical Physiology and Pharmacology · 14.07.2026
DOI: 10.1515/jbcpp-2026-0145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, online erschienen am 14.07.2026. Verfasst von Deniz Irem Caglayaner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Graduate School of Science, Uskudar University, Istanbul, Türkiye. Die Arbeit nennt 68 Literaturangaben.
Abstract (Originalsprache)
Objectives
Diabetic retinopathy (DR) causes retinal detachment, capillary degeneration, and diabetic macular edema. Chronic hyperglycemia leads to the formation of advanced glycation end products (AGEs). This activates the receptor for advanced glycation end-products (RAGE) signaling pathway, resulting in inflammation, oxidative stress, and cellular issues in the retina. The AGE-RAGE axis and signaling pathways are attractive therapeutic targets.
Methods
This study investigated the protective effects of trans-anethole (TA) and the RAGE inhibitor FPS-ZM1 in an in vitro model of high glucose-induced retinal injury. Both compounds were initially evaluated by molecular docking against GSK-3β. As FPS-ZM1 demonstrated higher predicted binding affinity than TA, further computational analyses, including molecular dynamics simulations and MM/GBSA binding free energy calculations, were performed only for FPS-ZM1.
Results
Both only TA and its combination with FPS-ZM1 greatly improved the healing response when glucose levels were high. This suggests that TA may have considerable therapeutic potential for wound healing. In addition, molecular docking and molecular dynamics simulations revealed that FPS-ZM1 may interact with GSK-3β ligand binding site.
Conclusions
Further investigations utilizing in vivo models are necessary to validate the inhibitory impact of FPS-ZM1 on GSK-3β and to elucidate the molecular mechanisms responsible for the protective benefits of trans-anethole.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Graduate School of Science, Uskudar University, Istanbul, Türkiye.
- Applied Informatics Department, Informatics Institute, Istanbul Technical University, Istanbul, Türkiye.
- Department of Molecular Biology and Genetics, Uskudar University, Istanbul, Türkiye.
Zitieren
APA
Caglayaner, D. I., Arslantas, Z., Kemaloğlu, F., Baday, S., & Atasever-Arslan, B. (2026). Targeting the AGE-RAGE/GSK-3β axis in diabetic retinopathy: wound-healing effects of trans-anethole and FPS-ZM1 and putative GSK-3β inhibitory activity of FPS-ZM1. Journal of Basic and Clinical Physiology and Pharmacology. https://doi.org/10.1515/jbcpp-2026-0145
Vancouver
Caglayaner DI, Arslantas Z, Kemaloğlu F, Baday S, Atasever-Arslan B. Targeting the AGE-RAGE/GSK-3β axis in diabetic retinopathy: wound-healing effects of trans-anethole and FPS-ZM1 and putative GSK-3β inhibitory activity of FPS-ZM1. Journal of Basic and Clinical Physiology and Pharmacology. 2026. doi:10.1515/jbcpp-2026-0145
BibTeX
@article{Caglayaner2026,
author = {Caglayaner, Deniz Irem and Arslantas, Zeynep and Kemaloğlu, Fatih and Baday, Sefer and Atasever-Arslan, Belkis},
title = {Targeting the AGE-RAGE/GSK-3β axis in diabetic retinopathy: wound-healing effects of trans-anethole and FPS-ZM1 and putative GSK-3β inhibitory activity of FPS-ZM1},
journal = {Journal of Basic and Clinical Physiology and Pharmacology},
year = {2026},
doi = {10.1515/jbcpp-2026-0145}
}
EUVIMED